Five Oceans Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
SAM
GA
PFS
AIP
ONB
VFM
QCM
ERP
BIAS
Five Oceans Advisors's NVO Position: Q2 2026 in Review
Five Oceans Advisors increased its Novo Nordisk (NVO) stake by 7.1% in Q2 2026, buying an estimated $21K and bringing the position to 7,396 shares worth $355K. The position accounts for 0.11% of the portfolio, ranked #119.
Five Oceans Advisors first reported a position in NVO in Q3 2021 and has held it in 20 quarters since. The position peaked at $2.88M in Q1 2024. 205 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Five Oceans Advisors held 7,396 shares of Novo Nordisk worth $355K as of Q2 2026.
- Five Oceans Advisors bought 489 Novo Nordisk shares in Q2 2026, an estimated $21K.
- Novo Nordisk made up 0.11% of Five Oceans Advisors's portfolio in Q2 2026, its #119 holding.
- Five Oceans Advisors first reported a position in Novo Nordisk in Q3 2021 and has held it in 20 quarters since.
- Five Oceans Advisors's Novo Nordisk position peaked at $2.88M in Q1 2024.
- 205 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Five Oceans Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.